References
AL-Sa’adi, W., Warka’a, T., Abdulmunem, R. and Raed, L. (2015) 'Hs-CRP and Haptoglobin Levels in Iraqi Patients with Coronary Artery Disease’, Journal of the Faculty of Medicine Baghdad, 57(1), pp. 84-86. Available at: https://doi.org/10.32007/jfacmedbagdad.571318 Al-Hindi, H., Mousa, M., Al-Kashwan, T., Sudan, A. and Abdul-Razzaq, S. (2019) ‘On admission levels of high sensitive C-Reactive protein as A biomarker in acute myocardial infarction: A case-control study’, Indian Journal of Public Health, 10(4), p.1481.Available at: https://doi.org/10.5958/0976-5506.2019.00924.0 Andersson, J., Johansson, L., Ladenvall, P., Wiklund, P., Stegmayr, B., Jern, C. and Boman, K. (2009) ‘C-reactive protein is a determinant of first-ever stroke: Prospective nested case- referent study’, Cerebrovascular diseases (Basel, Switzerland), 27(6), pp. 544–551. Available at: https://doi.org/10.1159/000214217 Ansar, W. and Ghosh, S. (2013) ‘C-reactive protein and the biology of disease’, Immunologic research, 56(1), pp. 131–142. Available at: https://doi.org/10.1007/s12026-013-8384-0 Banait, T., Wanjari, A., Danade, V., Banait, S. and Jain, J. (2022) ‘Role of high-sensitivity C- reactive protein (Hs-CRP) in non-communicable diseases: A review’, Cureus, 14(10), Available at: https://doi.org/10.7759/cureus.30225 Béjot, Y., Bailly, H., Durier, J. and Giroud, M. (2016) ‘Epidemiology of stroke in Europe and trends for the 21st century’, La Presse Médicale, 45(12), pp. e391–e398. Available at: https://doi.org/10.1016/j.lpm.2016.10.003 Bienek, R., Marek, B., Kajdaniuk, D., Borgiel-Marek, H., Piecha, T., Nowak, M., Siemi?ska, L., G?ogowska-Szel?g, J., Foltyn, W. and Kos-Kud?a, B. (2012) ‘Adiponectin, leptin, resistin and insulin blood concentrations in patients with ischaemic cerebral stroke’, Endokrynologia Polska, 63(5), pp.338-345. Available at: https://journals.viamedica.pl/endokrynologia_polska/article/view/25144(Accessed on 04/08/2024) Boehme, A., Esenwa, C. and Elkind, M. (2017) ‘Stroke risk factors, genetics, and prevention’, Circulation research, 120(3), pp.472-495. Available at: https://doi.org/10.1161/CIRCRESAHA.116.308398 Donkor, E. (2018) ‘Stroke in the21stCentury: A snapshot of the burden, epidemiology, and quality of life’, Stroke research and treatment, 2018(1), pp. 3238165. Available at: https://doi.org/10.1155/2018/3238165 Flora, G. D., & Nayak, M. K. (2019). A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Current pharmaceutical design, 25(38), 4063-4084. Frak, W., Wojtasinska, A., Lisinska, W., Mlynarska, E., Franczyk, B. and Rysz, J. (2022) ‘Pathophysiology of Cardiovascular diseases: New insights into Molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease’, Biomedicines, 10(8), pp. 1938. Available at: https://doi.org/10.3390/biomedicines10081938 Gagnier, J., Moher, D., Boon, H., Beyene, J. and Bombardier, C. (2012) ‘Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature’, BMC medical research methodology, 12(1), pp. 111. Available at: https://doi.org/10.1186/1471-2288-12-111 Gan, Y., Jiang, H., Room, R., Zhan, Y., Li, L., Lu, K. and Wang, C. (2021) ‘Prevalence and risk factors associated with stroke in China: a nationwide survey of 726,451 adults’, European journal of preventive cardiology, 28(12), pp. e6–e10.Available at: https://doi.org/10.1177/2047487320902324 Golbidi, S., Frisbee, J. and Laher, I. (2015) ‘Chronic stress impacts the cardiovascular system: animal models and clinical outcomes’, American Journal of Physiology-Heart and Circulatory Physiology, 308(12), Available at: https://doi.org/H-00859-2014 Golledge, J., Velu, R., Quigley, F., Jenkins, J. and Singh, T. (2023) ‘The predictive value of four serum biomarkers for major adverse events in patients with small abdominal aortic aneurysm’, Journal of vascular surgery, 77(4), pp. 1037–1044. Available at: https://doi.org/10.1016/j.jvs.2022.12.001 Huang, Y., Jing, J., Zhao, X., Wang, C., Wang, Y., Liu, G., Wang, C., Liu, L., Yang, X., Jiao, Y. and Jiao, Y. (2012) ‘High?sensitivity C?reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese’, CNS neuroscience & therapeutics, 18(3), pp.261-266. Available at: https://doi.org/10.1111/j.1755-5949.2012.00296.x Kara, H., Akinci, M., Degirmenci, S., Bayir, A., Ak, A., Nayman, A., Unlu, A., Akyurek, F. and Sivri, M. (2014) ‘High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke’, Neuropsychiatric disease and treatment, 10 (2014), pp.1451-1457. Available at: https://doi.org/10.2147/ndt.s67665. Koosha, P., Roohafza, H., Sarrafzadegan, N., Vakhshoori, M., Talaei, M., Sheikhbahaei, E. and Sadeghi, M. (2020) ‘High sensitivity C-reactive protein predictive value for cardiovascular disease: A nested case control from Isfahan cohort study (ICS)’, Global heart, 15(1), pp. Available at: https://doi.org/10.5334/gh.367 Kuriakose, D. and Xiao, Z. (2020) ‘Pathophysiology and treatment of stroke: Present status and future perspectives’, International journal of molecular sciences, 21(20), pp. 7609. Available at: https://doi.org/10.3390/ijms21207609 Kusvuran Ozkan, A., Umit Yemisci, O., Nur Saracgil Cosar, S., Oztop, P. and Turhan, N. (2013) ‘Can high-sensitivity C-reactive protein and ferritin predict functional outcome in acute ischemic stroke? A prospective study.’, Topics in Stroke Rehabilitation, 20(6), pp. 528– Available at: https://doi.org/10.1310/tsr2006-528 Lee, A., Lucero, B., Palmer, L., Jones, J. and Young, J. (2013) ‘Inflammatory biomarkers for predicting cardiovascular disease’, Clinical biochemistry, 46(15), pp. 1353–1371. Available at: https://doi.org/10.1016/j.clinbiochem.2013.05.070 Li, W., Xiong, L., Fan, L., Wang, Y., Peng, X., Rong, R., Qiu, Y., Shen, J., Lin, J., Yu, X. and Mao, H. (2017)’, Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients’, BMC nephrology, 18, pp.1-10. Available at: https://doi.org/10.1186/s12882-017-0624-4. Lin, F., Chen, Y., Wan, M., Chen, W. and Jia, W. (2019) ‘High-sensitivity C-reactive protein as an indicator of ischemic stroke in patients with isolated acute vestibular syndrome: Retrospective observational study’, Medicine, 98(48), pp. e18097. Available at: https://doi.org/10.1097/md.0000000000018097 Liu, G., Dong, M., Ma, S., Fu, L., Xiao, Y., Zhong, L. and Geng, J. (2019) ‘Serum leptin is associated with first-ever ischemic stroke, lesion size and stroke severity in a Chinese cohort’, Neurological research, 41(2), pp. 125–131. Available at: https://doi.org/10.1080/01616412.2018.1544399 Liu, Y., Wang, J., Zhang, L., Wang, C., Wu, J., Zhou, Y., Gao, X., Wang, A., Wu, S. and Zhao, X., 2014 ‘Relationship between C-reactive protein and stroke: a large prospective community based study’, PloS one, 9(9), pp.e107017.Available at: https://doi.org/10.1371/journal.pone.0107017 Luan, Y. and Yao, Y. (2018) ‘The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases’, Frontiers in immunology, 9, pp. 1302 doi: https://doi.org/10.3389/fimmu.2018.01302 Maki-Alhindi, H., Mousa, M., Al-kashwan, T., Sudan, A. and Abdul-Razzaq, S. (2019) ‘On admission levels of high sensitive C-reactive protein as A biomarker in acute myocardial infarction: A case-control study’, Indian journal of public health research and development, 10(4), pp. Available at: https://doi.org/10.5958/0976- 5506.2019.00924.0. Menon, B. and Krishnan, R. (2018) ‘Role of Leptin in acute ischemic stroke’, Journal of neurosciences in rural practice, 0